GlassScriptPhysician profile
Lena Su Carr
NPI 1699034215
$4,010.09
in general payments reported to CMS, 2019-2025
33 companies · $408 in 2025
The $408 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $278 · 2021: $416 · 2022: $1,397 · 2023: $825 · 2024: $562 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $639.98 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Aspira Women'S Health INC | $578.58 | 2020-2025 | Ova1 |
| Sumitomo Pharma America, INC. | $506.12 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $410.02 | 2021-2022 | |
| Sage Therapeutics, LLC | $207.23 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $164.40 | 2019-2022 | |
| Exeltis, USA INC. | $134.30 | 2021-2025 | Slynd |
| Applied Medical Resources Corporation | $130.75 | 2021-2022 | |
| Coopersurgical, INC. | $110.41 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $92.66 | 2021-2024 | Myosure Tissue Removal Device, Omni Hysteroscope, Novasure |
| Agile Therapeutics, INC. | $91.25 | 2021-2023 | Twirla |
| Mylan Pharmaceuticals INC. | $81.33 | 2019-2022 | |
| Baxter Healthcare | $78.73 | 2024-2025 | Perclot |
| Daiichi Sankyo INC. | $76.80 | 2022-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $75.20 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $69.54 | 2023 | Myrisk |
| Pfizer INC. | $68.99 | 2021-2024 | |
| Astellas Pharma US INC | $66.41 | 2023-2024 | Veozah |
| Channel Medsystems, INC. | $66.16 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.91 | 2021-2025 | |
| Mimedx Group, INC. | $59.41 | 2024 | |
| Amag Pharmaceuticals, INC. | $52.68 | 2019-2022 | |
| Organon LLC | $33.39 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $21.09 | 2022 | |
| Shield Therapeutics INC | $21.01 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $19.08 | 2022 | |
| Gynesonics, INC. | $18.11 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Becton, Dickinson and Company | $16.54 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Scynexis, INC. | $12.68 | 2022 | |
| Allergan, INC. | $12.54 | 2020 | |
| Acessa Health INC. | $11.90 | 2019 | |
| Zyla Life Sciences, INC. | $11.76 | 2020 | |
| Vertical Pharmaceuticals, LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lena Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.